Literature DB >> 22437081

Control to goal of cardiometabolic risk factors among Nigerians living with type 2 diabetes mellitus.

C I Okafor1, E N Ofoegbu.   

Abstract

BACKGROUND: Cardiovascular risk factors contribute to morbidity and mortality among diabetic patients. National and international guidelines on management of diabetes therefore emphasize control to goals of blood glucose, blood pressure, dyslipidemia, and obesity so as to minimize the development of complications and enhance the patients' quality of life.
OBJECTIVE: To evaluate the status of control to goals of cardiometabolic risk factors among the diabetic patients attending the Diabetes clinic of University of Nigeria Teaching Hospital, Enugu.
MATERIALS AND METHODS: A survey of 233 type 2 diabetic patients recruited from the Diabetes clinic of our hospital was carried out. Standard procedures as described in the WHO STEP instrument were used to determine the waist circumference, weight, height, and systolic and diastolic blood pressure. Fasting blood glucose and lipid profiles were also assessed. Therapeutic goals used to define risk or poor control were values adopted by expert groups such as American diabetes association (ADA), National cholesterol education program (NCEP), American association of clinical endocrinologist (AACE) and International diabetes federation (IDF).
RESULTS: There were 98 males and 135 females with mean (SD) duration of diabetes mellitus (DM) of 6.7 (6.3) years. Suboptimal glycemic, blood pressure control and dyslipidemia were observed in 65.7%, 51.9%, 97.1% of the subjects respectively while 60.1% of the subjects were found to be overweight/obese. Comparing the mean indices of risk factors with the recommended therapeutic goals, status of control was optimal for HDL-cholesterol, waist circumference and triglycerides. All the other risk factors were suboptimal.
CONCLUSION: Control to goals of cardiovascular risk factors is poor among the patients. There is the need to identify and tackle the possible contributing factors so as to reduce the morbidity and mortality in these patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22437081     DOI: 10.4103/1119-3077.94089

Source DB:  PubMed          Journal:  Niger J Clin Pract            Impact factor:   0.968


  5 in total

1.  Prevalence of Obesity and Its Influence on Achievement of Cardiometabolic Therapeutic Goals in Chinese Type 2 Diabetes Patients: An Analysis of the Nationwide, Cross-Sectional 3B Study.

Authors:  Xianghai Zhou; Linong Ji; Xingwu Ran; Benli Su; Qiuhe Ji; Changyu Pan; Jianping Weng; Changsheng Ma; Chuanming Hao; Danyi Zhang; Dayi Hu
Journal:  PLoS One       Date:  2016-01-04       Impact factor: 3.240

2.  Influence of gender on the distribution of type 2 diabetic complications at the obafemi awolowo teaching hospital, Ile-Ife, Nigeria.

Authors:  Adenike Enikuomehin; Babatope A Kolawole; Olubukunmi D Soyoye; Joseph O Adebayo; Rosemary T Ikem
Journal:  Afr Health Sci       Date:  2020-03       Impact factor: 0.927

3.  Blood Glucose Control and Medication Adherence Among Adult Type 2 Diabetic Nigerians Attending A Primary Care Clinic in Under-resourced Environment of Eastern Nigeria.

Authors:  Iloh Gu Pascal; John N Ofoedu; Njoku P Uchenna; Amadi A Nkwa; Godswill-Uko E Uchamma
Journal:  N Am J Med Sci       Date:  2012-07

4.  Adequacy of control of cardiovascular risk factors in ambulatory patients with type 2 diabetes attending diabetes out-patients clinic at a county hospital, Kenya.

Authors:  Mercy W Kimando; Frederick C F Otieno; Elijah N Ogola; Kenn Mutai
Journal:  BMC Endocr Disord       Date:  2017-12-01       Impact factor: 2.763

5.  Association between glycemic status and thyroid dysfunction in patients with type 2 diabetes mellitus.

Authors:  S U Ogbonna; I U Ezeani; C I Okafor; S Chinenye
Journal:  Diabetes Metab Syndr Obes       Date:  2019-07-12       Impact factor: 3.168

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.